United Therapeutics (NASDAQ:UTHR) Price Target Raised to $414.00

United Therapeutics (NASDAQ:UTHR – Free Report) had its price target increased by Wells Fargo & Company from $295.00 to $414.00 in a report published on Wednesday,Benzinga reports. The firm currently has an equal weight rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. HC Wainwright set a $400.00 […]

Leave a Reply

Your email address will not be published.

Previous post Vir Biotechnology (NASDAQ:VIR) Research Coverage Started at Evercore ISI
Next post Freddie Mac (OTCMKTS:FMCC) versus Onity Group (NYSE:ONIT) Head-To-Head Survey